Asia-Pacific Injection Pen Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Disposable Injection Pens and Reusable Injection Pens), Therapy (Diabetes, Growth Hormone Therapy, Autoimmune Diseases, Fertility, Cancer, and Others Therapy), and End User (Hospitals and Clinics, Home Care, and Others)
The Asia-Pacific injection pen market is expected to grow from US$ 11,116.23 million in 2022 to US$ 17,161.96 million by 2028. It is estimated to register a CAGR of 7.5% from 2022 to 2028.
Technological Advancements and Healthcare Waste Reduction in Asia-Pacific Injection Pen Market
There has been a notable growth in the use of injection pens to treat various chronic disorders such as cancer, diabetes, cardiovascular disorders, and multiple sclerosis. The increase in home healthcare has further propelled the demand for injection pens. This has boosted the technological advancements in injection pens. Manufacturers are focused on developing the next-generation smart insulin pen to deliver metered insulin dosage. For instance, Medtronic plc launched InPen integrated with real-time Guardian Connect CGM data. InPen is the first and only FDA-cleared smart insulin pen in the market for people on multiple daily injections (MDI). This integrated system provides real-time glucose readings alongside insulin dose information, giving users everything they need to manage their diabetes. Rather than switching between apps, users can see all the required information in real-time in one view, making it easier to make smarter dosing decisions to manage their sugar levels. Furthermore, using artificial intelligence will be the game changer, as it will keep track of doses, dates, and timing of drugs or insulin, which will be beneficial in the long term and helpful for the treatment and management of various conditions. Conventional syringes used to deliver insulin and other injectables can be painful and uncomfortable for the patient daily, and they also generate a huge quantity of healthcare waste. Approximately 73% of insulin waste is associated with the use of conventional technology. With the use of injection pens, this waste is reduced to 3.6%, making a huge difference. Therefore, technological advancements and a rise in demand for the reduction of healthcare wastage are among the trends expected to propel the growth of the injection pen market in the coming years.
Asia-Pacific Injection Pen Market Overview
The Asia Pacific injection pen market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China held the largest share of the market in 2021, and India is expected to exhibit a significant growth rate in the market. The market growth in these countries is attributed to the advancements in the treatment of diabetes. Moreover, the Chinese Diabetes Society has taken the lead in insulin injection education in the past decade to treat diabetes. Therefore, with the high awareness of injection pens and the usability of needle injections intended for the diabetic population in China, the market for injection pens will grow in the near future.
Asia-Pacific Injection Pen Market Revenue and Forecast to 2028 (US$ Million)
Asia-Pacific Injection Pen Market Segmentation
The Asia-Pacific injection pen market is segmented on the basis of type, therapy, end user, and country. Based on type, the injection pen market is segmented into disposable injection pens and reusable injection pens. The disposable injection pens segment registered a larger market share in 2022.
Based on therapy, the Asia-Pacific injection pen market is segmented into diabetes therapy, growth hormone therapy, autoimmune diseases therapy, fertility therapy, cancer therapy, and others. The diabetes therapy segment registered the largest market share in 2022.
Based on end user, the Asia-Pacific injection pen market is segmented into hospitals & clinics, home care, and others. The home care segment registered the largest market share in 2022.
Based on country, the Asia-Pacific injection pen market is segmented into China, Japan, India, Australia, South Korea, and the Rest of APAC. The US dominated the market in 2022.
AstraZeneca Plc, Becton Dickinson and Co, Eli Lilly, and Co, Gerresheimer AG, Haselmeier GmbH, Merck KGaA, Novo Nordisk AS, Owen Mumford Ltd, Sanofi SA, and Teva Pharmaceutical Industries Ltd are among the leading companies operating in the Asia-Pacific injection pen market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia-Pacific Injection Pen Market – by Type
1.3.2 Asia-Pacific Injection Pen Market – by Therapy
1.3.3 Asia-Pacific Injection Pen Market – by End User
1.3.4 Asia-Pacific Injection Pen Market – by Country
2. Asia-Pacific Injection Pen Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia-Pacific Injection Pen Market – Market Landscape
4.1 Overview
4.2 Asia-Pacific PEST Analysis
4.3 Expert’s Opinion
5. Asia-Pacific Injection Pen Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Chronic Disorders
5.1.2 Increase in Strategic Developments
5.2 Market Restraints
5.2.1 Presence of Alternative Drug Delivery Devices and Inadequate Reimbursement Scenario
5.3 Market Opportunities
5.3.1 Increase in Biologics Patent Expiry and Use of Biosimilars
5.4 Future Trends
5.4.1 Technological Advancements and Healthcare Waste Reduction
5.5 Impact Analysis
6. Injection Pen Market – Asia-Pacific Analysis
6.1 Asia-Pacific Injection Pen Market Revenue Forecast and Analysis
7. Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 – by Type
7.1 Overview
7.2 Asia-Pacific Injection Pen Market Revenue Share, by Type 2021 & 2028 (%)
7.3 Disposable Injection Pens
7.3.1 Overview
7.3.2 Disposable Injection Pens: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Reusable Injection Pens
7.4.1 Overview
7.4.2 Reusable Injection Pens: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
8. Asia-Pacific Injection Pen Market Analysis and Forecast to 2028 – by Therapy
8.1 Overview
8.2 Asia-Pacific Injection Pen Market, by Therapy 2021 & 2028 (%)
8.3 Diabetes Therapy
8.3.1 Overview
8.3.2 Diabetes Therapy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Growth Hormone Therapy
8.4.1 Overview
8.4.2 Growth Hormone Therapy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Autoimmune Diseases Therapy
8.5.1 Overview
8.5.2 Autoimmune Diseases Therapy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Fertility Therapy
8.6.1 Overview
8.6.2 Fertility Therapy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Cancer Therapy
8.7.1 Overview
8.7.2 Cancer Therapy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Other Therapies
8.8.1 Overview
8.8.2 Other Therapies: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
9. Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 – by End User
9.1 Overview
9.2 Asia-Pacific Injection Pen Market Revenue Share, by End User 2021 & 2028 (%)
9.3 Home Care
9.3.1 Overview
9.3.2 Home Care: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Hospitals & Clinics
9.4.1 Overview
9.4.2 Hospitals & Clinics: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10. Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 – Country Analysis
10.1 Overview
10.1.1 Asia Pacific: Injection Pen Market, by Country, 2021 & 2028 (%)
10.1.1.1 China: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 China: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 China: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.1.1.1.4 China: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.1.1.1.5 China Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.1.1.2 Japan: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Japan: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Japan: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.1.1.2.4 Japan: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.1.1.2.5 Japan: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.1.1.3 India: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 India: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 India: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.1.1.3.4 India: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.1.1.3.5 India: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.1.1.4 South Korea: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 South Korea: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 South Korea: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.1.1.4.4 South Korea: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.1.1.4.5 South Korea: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.1.1.5 Australia: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Australia: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 Australia: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.1.1.5.4 Australia: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.1.1.5.5 Australia: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.1.1.6 Rest of Asia Pacific: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.1.1.6.4 Rest of Asia Pacific: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.1.1.6.5 Rest of Asia Pacific: Injection Pen Market, by End User, 2019–2028 (US$ Million)
11. Asia-Pacific Injection Pen Market – Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Eli Lilly and Co
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Novo Nordisk AS
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Owen Mumford Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Sanofi SA
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Merck KGaA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Haselmeier GmbH
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Gerresheimer AG
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Becton Dickinson and Co
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 AstraZeneca Plc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Teva Pharmaceutical Industries Ltd
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Table 2. China Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. China Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 4. China Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. Japan Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. Japan Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 7. Japan Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 8. India Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 9. India Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 10. India Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 11. South Korea Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. South Korea Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 13. South Korea Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 14. Australia Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 15. Australia Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 16. Australia Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Asia Pacific Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of Asia Pacific Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 19. Rest of Asia Pacific Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 20. Recent Inorganic Growth Strategies in the Injection Pen Market
Table 21. Recent Organic Growth Strategies in the Injection Pen Market
Table 22. Glossary of Terms
LIST OF FIGURES
Figure 1. Asia-Pacific Injection Pen Market Segmentation
Figure 2. Asia-Pacific Injection Pen Market, by Country
Figure 3. Asia-Pacific Injection Pen Market Overview
Figure 4. Asia-Pacific Injection Pen Market, by Type
Figure 5. Asia-Pacific Injection Pen Market, by Country
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Asia-Pacific Injection Pen Market: Impact Analysis of Drivers and Restraints
Figure 9. Asia-Pacific Injection Pen Market – Revenue Forecast and Analysis – 2020–2028
Figure 10. Asia-Pacific Injection Pen Market Revenue Share, by Type 2021 & 2028 (%)
Figure 11. Disposable Injection Pens: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Reusable Injection Pens: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Asia-Pacific Injection Pen Market, by Therapy 2021 & 2028 (%)
Figure 14. Diabetes Therapy: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Growth Hormone Therapy: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Autoimmune Diseases Therapy: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Fertility Therapy: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Cancer Therapy: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Other Therapies: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Asia-Pacific Injection Pen Market Revenue Share, by End User 2021 & 2028 (%)
Figure 21. Home Care: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Hospitals & Clinics: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Others: Asia-Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Asia Pacific: Injection Pen Market, by Key Country – Revenue (2021) (US$ Million)
Figure 25. China: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Japan: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. India: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. South Korea: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Australia: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Rest of Asia Pacific: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
- AstraZeneca Plc
- Becton Dickinson and Co
- Eli Lilly and Co
- Gerresheimer AG
- Haselmeier GmbH
- Merck KGaA
- Novo Nordisk AS
- Owen Mumford Ltd
- Sanofi SA
- Teva Pharmaceutical Industries Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia-Pacific injection pen market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia-Pacific injection pen market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia-Pacific market trends and outlook coupled with the factors driving the injection pen market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution